Tweet Archive for hashtag “#Ipsen” « page 2

Long-Term (36 months) Safety of AbobotulinumtoxinA for the Treatment of Glabellar Lines onlinelibrary.wiley.com/doi/10.1111/ds… #Ipsen #Dysport #Azzalure

5:40am Jan 20 2014 —

Controlled Comparative Study Between Abo BoNT-A vs Ona BoNT-A for Facial Rhytids link.springer.com/article/10.100… #Allergan #botox #Ipsen #Dsyport

6:36pm Dec 26 2013 —

Long-Term (36 months) Safety of AbobotulinumtoxinA for Glabellar Lines onlinelibrary.wiley.com/doi/10.1111/ds… #dysport #reloxin #azzalure #Ipsen #Valeant

3:32pm Dec 26 2013 —

QoL and Satisfaction of Patients after Full-Face Injections w/ BoNTA-ABO jddonline.com/articles/derma…
…by Doris Hexsel #Ipsen #dysport #reloxin

8:39am Dec 6 2013 —

Full-Face Injections of Variable Total Doses of BoNTA-ABO : Phase IV RCT jddonline.com/articles/derma… by Doris Hexsel #Ipsen #dysport #reloxin

6:13am Dec 5 2013 —

Swiss discovery promises safer Botox in future zite.to/1cDX3JV #botox #allergan #dysport #ipsen #galderma

3:04pm Nov 18 2013 —

The Wrinkle Wars: Botox Vs. Dysport zite.to/193kGrU #Allergan #Ipsen #Valeant #cosmeticdermatology

5:29pm Nov 7 2013 —

RT @KnowYrMoles: Not all #botulinumToxin is the same, says #Allergan funded study m.aes.sagepub.com/content/33/7/1… #Ipsen #Galderma #Merz

in reply to KnowYrMoles — 3:13am Oct 11 2013 —

Clinical relevance of botulinum toxin immunogenicity ncbi.nlm.nih.gov/pubmed/22385408 #Allergan #Merz #Ipsen #Galderma #cosmeticdermatology

1:26pm Oct 10 2013 —

Treatment of palmar hyperhidrosis with BoNT-A: novel injective approach link.springer.com/article/10.100… #Allergan #Galderma #Ipsen #Merz

10:42am Sep 24 2013 —